OXcan raise millions in funding
Congratulations to NHS Market Access Accelerator alumnus Oxford Cancer Analytics (OXcan)! They, with help from MAA partners Taylor Wessing, have secured $11million in Series A funding from global investors, a strong indicator of the potential of their early lung cancer detection solution. Alongside this incredible raise they’ve also been able to expand their team, appointing […]
